阿司匹林在致癌作用中的角色。
The role of aspirin in carcinogenesis.
作者信息
Caine G J, Kehoe S T, Lip G Y H
出版信息
Br J Cancer. 2002 Nov 18;87(11):1337-8. doi: 10.1038/sj.bjc.6600670.
Abstract
(2002) , 1337–1338. doi:10.1038/sj.bjc.6600670 www.bjcancer.com © 2002 Cancer Research UK
摘要
（2002年），第1337 - 1338页。doi:10.1038/sj.bjc.6600670 www.bjcancer.com © 2002英国癌症研究中心
相似文献
1
The role of aspirin in carcinogenesis.阿司匹林在致癌作用中的角色。
Br J Cancer. 2002 Nov 18;87(11):1337-8. doi: 10.1038/sj.bjc.6600670.
2
3
The molecular perspective: cyclooxygenase-2.
Oncologist. 2000;5(2):169-71. doi: 10.1634/theoncologist.5-2-169.
4
Aspirin and colon cancer--targeting prevention?阿司匹林与结肠癌——靶向预防？
N Engl J Med. 2007 May 24;356(21):2195-8. doi: 10.1056/NEJMe078044.
5
Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.慢性低剂量阿司匹林治疗对三种肠道肿瘤发生小鼠模型肿瘤预防的影响。
Cancer Med. 2020 Apr;9(7):2535-2550. doi: 10.1002/cam4.2881. Epub 2020 Jan 29.
6
Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment.分子途径：阿司匹林与Wnt信号传导——癌症预防与治疗的分子靶向方法
Clin Cancer Res. 2015 Apr 1;21(7):1543-8. doi: 10.1158/1078-0432.CCR-14-0877. Epub 2014 Dec 11.
7
The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs).环氧化酶抑制在非甾体抗炎药（NSAIDs）抗肿瘤作用中的角色。
J Exp Med. 1999 Aug 16;190(4):445-50. doi: 10.1084/jem.190.4.445.
8
[Aspirin, non-steroidal anti-inflammatory agents and colonic carcinogenesis].[阿司匹林、非甾体抗炎药与结肠癌发生]
Gastroenterol Clin Biol. 1997;21(3):188-96.
9
Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.
Carcinogenesis. 1990 Mar;11(3):393-5. doi: 10.1093/carcin/11.3.393.
10
An aspirin a day: the allure (and distraction) of chemoprevention.每日一片阿司匹林：化学预防的魅力（与干扰因素）。
J Natl Cancer Inst. 2012 Dec 5;104(23):1782-4. doi: 10.1093/jnci/djs462. Epub 2012 Nov 28.
本文引用的文献
1
Aspirin and lung cancer in women.阿司匹林与女性肺癌
Br J Cancer. 2002 Jul 1;87(1):49-53. doi: 10.1038/sj.bjc.6600370.
2
Sulphation catalysed by the human cytosolic sulphotransferases--chemical defence or molecular terrorism?人胞质磺基转移酶催化的硫酸化作用——化学防御还是分子恐怖主义？
Hum Exp Toxicol. 1996 Jul;15(7):547-55. doi: 10.1177/096032719601500701.
3
Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).人磺基转移酶对N-羟基芳胺和N-羟基杂环胺的代谢激活作用。
Cancer Res. 1995 Feb 1;55(3):525-9.
4
Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis by N-nitrosobis(2-oxopropyl)amine in hamsters.硫酸化抑制剂对N-亚硝基双（2-氧代丙基）胺诱发仓鼠胰腺导管癌起始阶段的抑制作用。
Carcinogenesis. 1995 Mar;16(3):457-9. doi: 10.1093/carcin/16.3.457.
5
6
Pathways involved in the metabolism and activation of polycyclic hydrocarbons.多环烃代谢与活化所涉及的途径。
Xenobiotica. 1986 Oct-Nov;16(10-11):915-31. doi: 10.3109/00498258609038974.
7
Human liver arylamine N-sulfotransferase activity. Thermostable phenol sulfotransferase catalyzes the N-sulfation of 2-naphthylamine.人肝脏芳基胺N-磺基转移酶活性。耐热性酚磺基转移酶催化2-萘胺的N-硫酸化反应。
Drug Metab Dispos. 1991 Nov-Dec;19(6):1071-9.
8
Inhibition of aryl sulfotransferase by carboxylic acids.
Drug Metab Dispos. 1991 Mar-Apr;19(2):543-5.
Zotero 插件